Release of raw patient data to international researchers from most countries would be unusual, and even if a strong case were made it would have to undergo ethics committee approval, which would take months.
> The team had requested raw patient data on 174 cases that China had identified from the early phase of the outbreak in the city of Wuhan in December 2019, as well as other cases, but were only provided with a summary, said Dominic Dwyer, an Australian infectious diseases expert who is a member of the team.
> Such raw data is known as “line listings”, he said, and would typically be anonymised but contain details such as what questions were asked of individual patients, their responses and how their responses were analysed.
> “That’s standard practice for an outbreak investigation,” he told Reuters on Saturday via video call from Sydney, where he is currently undergoing quarantine.
I can't claim to know much about what's standard practice for outbreak investigations, but I'm inclined to believe him on this more than - no offense - a random HN user.
